← Back to Search

A Nasal Applicator for the Treatment of Trigeminal Neuralgia

N/A
Waitlist Available
Led By Kenneth D Candido, M.D.
Research Sponsored by Chicago Anesthesia Pain Specialists
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before procedure and after procedure
Awards & highlights
No Placebo-Only Group

Summary

The pain from Trigeminal Neuralgia (TN) imposes a substantial burden on patients in daily function and reduces quality of life. The sphenopalatine ganglion, located in the posterior part of the middle nasal turbinate, is involved in the pain associated to TN, by blocking the sphenopalatine ganglion relieves patients from the symptoms. However, methods currently in use to accomplish this are either cumbersome for the patient or invasive regarding the puncture of structures. The purpose of this study is to evaluate the efficacy of Tx360™, a new nasal applicator device, in the treatment of TN. A local anesthetic will be delivered on the ganglion area. We are expecting that this new device will provide at least the same pain relief as the previously described approaches. However, this nasal applicator is intended to be an easy and non invasive method for office use.

Eligible Conditions
  • Trigeminal Neuralgia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and after procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pain intensity numeric rating scale
Secondary study objectives
Patient's global impression of change
Other study objectives
Modified Brief Pain inventory (short form)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Nasal ganglion block for TNExperimental Treatment1 Intervention
Sphenopalatine ganglion block using the Tx360™ device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nasal ganglion block for TN
2011
N/A
~10

Find a Location

Who is running the clinical trial?

Chicago Anesthesia Pain SpecialistsLead Sponsor
3 Previous Clinical Trials
184 Total Patients Enrolled
Kenneth D Candido, M.D.Principal InvestigatorChicago Anesthesia Pain Specialists
2 Previous Clinical Trials
76 Total Patients Enrolled
~1 spots leftby Dec 2025